Signant Health Unveils its full Conference Line-up for SCOPE 2020 Published on: February 11, 2020 Back to Newsroom PHILADELPHIA, PA – February 11, 2020: The SCOPE Summit for Clinical Operations Executives annually convenes innovative thought leaders from across the life sciences industry to share ideas, challenges and best practices that will help drive change and improve patient-centricity throughout the coming year and beyond. Subject matter experts from Signant Health will host and participate in key discussions on the importance of eConsent and patient engagement, the impact of data analytics on endpoint quality, and how to integrate sensors and wearables into eCOA trials as part of the patient journey through clinical research. Join the conversation at SCOPE with these engaging sessions: Keynote Panel – Taking the Plunge: Why Now is the Time to Invest in eConsent and Patient Engagement Moderated by Bill Byrom, MD | VP, Product Strategy and Innovation Featuring panellists Michelle Shogren (Bayer Pharmaceuticals), Hassan Kadhim (Bristol Myers-Squibb), Kelly McKee (Vertex Pharmaceuticals) and Gretchen Goller (ICON plc)Tuesday, February 18 at 5:05pm Mobile Sensors in Clinical Trials and Evidentiary Considerations for Electronic Submissions Presented by Dr. Byrom Wednesday, February 19 at 10:55am Using Advanced Risk-Based Monitoring Models to Improve Endpoint Quality Presented by Todd Everhart, MD | Clinical Vice President, Internal Medicine Wednesday, February 19 at 12:50pm Navigating the Patient Journey: A Responsibility All Technology Providers Share Presented by Mike Nolte | CEO Thursday, February 20 at 7:45am Novel Digital Endpoints in Clinical Research: Technology, Infrastructure, Relationship with Technology Providers Moderated by Michelle Crouthamel (AbbVie) Featuring panellists Mike Nolte, Jeremy Wyatt (Actigraph), Jennifer Goldsack (DiMe) and Sina Djali (Johnson & Johnson)Thursday, February 20 at 11:45am Enable Empowered Patients in Clinical Trials By Integrating the Patient’s Voice, Health Literacy and Cultural Sensitivity Sessions chaired by Chris Crucitti | Chief Commercial Officer Thursday, February 20 at 4:10pm Visitors to the Signant Health exhibit booth will have the opportunity to meet with subject matter experts, technologists and scientists and go hands-on with the latest patient-centric technologies including eCOA, sensors and wearables, eConsent, patient engagement, IRT and more. Mike Nolte, CEO of Signant Health said, “Many of our partners and colleagues see opportunities to transform clinical research through the eyes of the patient. For us, this is deeply personal, and the beauty of SCOPE is that it brings together all of the people who are in the position – and who have the passion – to make that change a reality. SCOPE is a unique gathering because it links great leaders to great thinking that spans the tactical and strategic. We are proud to get the opportunity to collaborate and share with partners and colleagues across so many critical themes and challenges within clinical research.”